Literature DB >> 15364199

Functions of myc:max in the control of cell proliferation and tumorigenesis.

Peter J Hurlin1, Shala Dezfouli.   

Abstract

Deregulation and elevated expression of members of the Myc family of bHLHZip transcription factors are observed in a high percentage of tumors. This close association with human cancers has led to a tremendous effort to define their biological and biochemical activities. Although Myc family proteins have the capacity to elicit a wide range of cell behaviors, their principal function appears to be to drive cells into the cell cycle and to keep them there. However, forced expression of Myc profoundly sensitizes normal cells to apoptosis. Therefore, tumor formation caused by deregulated Myc expression requires cooperating events that disrupt pathways that mediate apoptosis. Myc-dependent tumor formation may also be impeded by a set of related bHLHZip proteins with the demonstrated potential to act as Myc antagonists in cell culture experiments. In this review, we examine the complex activities of Myc family proteins and how their actions might be regulated in the context of a network of bHLHZip proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15364199     DOI: 10.1016/S0074-7696(04)38004-6

Source DB:  PubMed          Journal:  Int Rev Cytol        ISSN: 0074-7696


  19 in total

Review 1.  MYC and transcription elongation.

Authors:  Peter B Rahl; Richard A Young
Journal:  Cold Spring Harb Perspect Med       Date:  2014-01-01       Impact factor: 6.915

2.  Cell-restricted immortalization by human papillomavirus correlates with telomerase activation and engagement of the hTERT promoter by Myc.

Authors:  Xuefeng Liu; Aleksandra Dakic; Renxiang Chen; Gary L Disbrow; Yiyu Zhang; Yuhai Dai; Richard Schlegel
Journal:  J Virol       Date:  2008-09-25       Impact factor: 5.103

3.  The impact of microRNA expression on cellular proliferation.

Authors:  Divya Lenkala; Bonnie LaCroix; Eric R Gamazon; Paul Geeleher; Hae Kyung Im; R Stephanie Huang
Journal:  Hum Genet       Date:  2014-03-08       Impact factor: 4.132

4.  Transcriptional amplification in tumor cells with elevated c-Myc.

Authors:  Charles Y Lin; Jakob Lovén; Peter B Rahl; Ronald M Paranal; Christopher B Burge; James E Bradner; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2012-09-28       Impact factor: 41.582

5.  Synthetic Lethality of PARP Inhibitors in Combination with MYC Blockade Is Independent of BRCA Status in Triple-Negative Breast Cancer.

Authors:  Jason P W Carey; Cansu Karakas; Tuyen Bui; Xian Chen; Smruthi Vijayaraghavan; Yang Zhao; Jing Wang; Keith Mikule; Jennifer K Litton; Kelly K Hunt; Khandan Keyomarsi
Journal:  Cancer Res       Date:  2017-11-27       Impact factor: 12.701

6.  CIP2A is a predictor of survival and a novel therapeutic target in bladder urothelial cell carcinoma.

Authors:  Yijun Xue; Gengqing Wu; Xiaoning Wang; Xiaofeng Zou; Guoxi Zhang; Rihai Xiao; Yuanhu Yuan; Dazhi Long; Jun Yang; Yuting Wu; Hui Xu; Folin Liu; Min Liu
Journal:  Med Oncol       Date:  2012-12-30       Impact factor: 3.064

7.  Multiple basic helix-loop-helix proteins regulate expression of the ENO1 gene of Saccharomyces cerevisiae.

Authors:  Meng Chen; John M Lopes
Journal:  Eukaryot Cell       Date:  2007-03-09

Review 8.  Multifunctional roles of enolase in Alzheimer's disease brain: beyond altered glucose metabolism.

Authors:  D Allan Butterfield; Miranda L Bader Lange
Journal:  J Neurochem       Date:  2009-09-23       Impact factor: 5.372

9.  Hypoxia induces differential translation of enolase/MBP-1.

Authors:  Kara C Sedoris; Shelia D Thomas; Donald M Miller
Journal:  BMC Cancer       Date:  2010-04-22       Impact factor: 4.430

Review 10.  B-cell receptor signaling in the genesis and maintenance of B-cell lymphoma.

Authors:  Ryan M Young; Brian C Turner; Yosef Refaeli
Journal:  Future Oncol       Date:  2008-10       Impact factor: 3.404

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.